CDK12/13 dual inhibitors are potential therapeutics for acute myeloid leukemia.
Lindsey SavoyNicola LongHyunjung LeeReid ChenBasil AllenHsin-Yun LinCristina E TognonSanjay V MalhotraJeffrey W TynerHaijiao ZhangPublished in: British journal of haematology (2023)